373 related articles for article (PubMed ID: 2903093)
1. Ovarian function after the menarche and hormonal contraception.
Borsos A; Lampé L; Balogh A; Csoknyay J; Ditròi F; Székely P
Int J Gynaecol Obstet; 1988 Oct; 27(2):249-53. PubMed ID: 2903093
[TBL] [Abstract][Full Text] [Related]
2. Ovarian function immediately after the menarche.
Borsos A; Lampé LG; Balogh A; Csoknyay J; Ditroi F
Int J Gynaecol Obstet; 1986 Jun; 24(3):239-42. PubMed ID: 2880764
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
4. The majority of irregular menstrual cycles in adolescence are ovulatory: results of a prospective study.
Peña AS; Doherty DA; Atkinson HC; Hickey M; Norman RJ; Hart R
Arch Dis Child; 2018 Mar; 103(3):235-239. PubMed ID: 28794095
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
6. Use of the Home Ovarian Monitor in pregnancy avoidance.
Brown JB; Holmes J; Barker G
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
[TBL] [Abstract][Full Text] [Related]
7. Mean versus individual hormonal profiles in the menstrual cycle.
Alliende ME
Fertil Steril; 2002 Jul; 78(1):90-5. PubMed ID: 12095496
[TBL] [Abstract][Full Text] [Related]
8. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
9. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
10. Symptothermal and hormonal markers of potential fertility in climacteric women.
Flynn AM; James P; Collins WP; Royston P
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):1987-9. PubMed ID: 1755454
[TBL] [Abstract][Full Text] [Related]
11. A pilot study on the utility of reduced urine collection frequency protocols for the assessment of reproductive hormones in adolescent girls.
Allaway HCM; John EM; Keegan TH; De Souza MJ
J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1083-1093. PubMed ID: 28949930
[TBL] [Abstract][Full Text] [Related]
12. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
[TBL] [Abstract][Full Text] [Related]
13. Menstrual Patterns in the First Gynecological Year: A Systematic Review.
Gunn HM; Tsai MC; McRae A; Steinbeck KS
J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):557-565.e6. PubMed ID: 30064002
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG
Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
[TBL] [Abstract][Full Text] [Related]
15. Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists.
Jay N; Mansfield MJ; Blizzard RM; Crowley WF; Schoenfeld D; Rhubin L; Boepple PA
J Clin Endocrinol Metab; 1992 Sep; 75(3):890-4. PubMed ID: 1517382
[TBL] [Abstract][Full Text] [Related]
16. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A
Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348
[TBL] [Abstract][Full Text] [Related]
17. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle.
Nelson AL
Am J Obstet Gynecol; 1997 Jun; 176(6):1376-80. PubMed ID: 9215201
[TBL] [Abstract][Full Text] [Related]
18. Body weight and the initiation of puberty.
Baker ER
Clin Obstet Gynecol; 1985 Sep; 28(3):573-9. PubMed ID: 4053451
[TBL] [Abstract][Full Text] [Related]
19. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
20. Ovulatory status and menstrual cycle duration assessed by self-collection of urine on pH strips in a population-based sample of French women not using hormonal contraception.
Rosetta L; Thalabard JC; Tanniou J; Ducot B; Maitrot-Mantelet L; Rousset-Jablonski C; Bohet A; Bouyer J; Chimenes A; Slama R
Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):450-458. PubMed ID: 29260590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
